- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04100213
Real-Time Assessment of Stress and Stress Response
June 25, 2023 updated by: Stephan T. Egger, Psychiatric University Hospital, Zurich
Stress is a complex natural phenomenon, frequently related to a physiological response, including heart rate, heart rate variability, respiratory rate, skin conductance and temperature.
The subjective experience varies greatly; broadly, it may be conceived as a freeze, flight, fight, fright or faint response.
Many studies have demonstrated the negative influence of psychological stress on health and well-being.
Through the digital phenotyping of physiological and psychological stress reactions, in a controlled laboratory setting (Trier Social Stress Test- TSST) and real-life situations, in a population of healthy participants and patients with a major psychiatric disorder, we expect to find reliable and valid digital biomarkers.
The results of this study will, therefore, not only contribute to a better understanding of stress and stress response but also have the potential to improve diagnostic and treatment approaches.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephan T. Egger, MD
- Phone Number: +41523049340
- Email: stephan.egger@puk.zh.ch
Study Locations
-
-
-
Zürich, Switzerland, 8032
- Recruiting
- Psychiatrische Universitätsklinik Zürich
-
Contact:
- Stephan T Egger, MD
- Phone Number: +4152304940
- Email: stephan.egger@puk.zh.ch
-
Contact:
- Godehard Weniger, MD
- Phone Number: +41523049341
- Email: godehard.weniger@puk.zh.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants are competent to give informed consent.
- Participants are right handed
- German language proficiency as a native speaker or level B1
- Diagnosis of a cluster C personality disorder according to ICD-10; or
- Diagnosis of depressive disorder according to ICD-10; or
- Diagnosis of schizophrenia or schizoaffective disorder according to ICD-10; or
- Without a current psychiatric disorder.
Exclusion Criteria:
- Low Intelligence as confirmed by failure to complete regular compulsory education.
- Pregnancy or over two weeks delay in the menstrual cycle.
- Previous participation in a psychological trial involving psychosocial stress assessment.
- Current neurological disorder.
- Current cardiovascular disorder.
- Current respiratory disorder.
- Current substance use or withdrawal.
- Any change in medication in the previous week.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TSST
|
The TSST-G is a psychological paradigm which combines high levels of social-evaluative threat and uncontrollability in a group setting.
The TSST-G will proceed in groups of three to five participants (from the same diagnostic group).
The TSST-G consists of three phases: a briefing; the psychological test itself, followed by a debriefing phase.
Each phase will last 40, 20 and 60 minutes, respectively.
The briefing and debriefing of the TSST-G will be conducted by experienced psychotherapists.
The TSST-G itself will be conducted by personal unknown to the participants.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cortisol
Time Frame: Change from 40 and 20 min. before the intervention. 0, 10, 20 30, 40, 60 and 80 min. after the intervention
|
Saliva Cortisol Concentration
|
Change from 40 and 20 min. before the intervention. 0, 10, 20 30, 40, 60 and 80 min. after the intervention
|
Subjective Stress
Time Frame: Change from 40 and 20 min. before the intervention. 0, 10, 20 30, 40, 60 and 80 min. after the intervention
|
Stress Questionnaire
|
Change from 40 and 20 min. before the intervention. 0, 10, 20 30, 40, 60 and 80 min. after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychopathological Assessement
Time Frame: 1 day
|
Symptom Questionnaire
|
1 day
|
Psychiatric Diagnosis
Time Frame: 1 day
|
Structured psychiatric Interview
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 1, 2023
Primary Completion (Estimated)
October 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
September 18, 2019
First Submitted That Met QC Criteria
September 19, 2019
First Posted (Actual)
September 24, 2019
Study Record Updates
Last Update Posted (Actual)
June 27, 2023
Last Update Submitted That Met QC Criteria
June 25, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mHealth TSST-G
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Baylor UniversityCompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Institut de Recherche Biomedicale des ArmeesCompletedPsychological Stresses
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
University of California, San FranciscoNational Institute on Aging (NIA); Penn State University; Harvard UniversityCompletedStress | Depressive Symptoms | Psychological Distress | Psychological Stress | Signs and Symptoms | Psychological | Child MaltreatmentUnited States
-
Penn State UniversityStony Brook University; National Institute on Aging (NIA); Oregon State University and other collaboratorsCompleted
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
Clinical Trials on Trier Social Stress Test
-
University Medical Center GroningenUniversity of GroningenRecruitingStress, Psychological | Stress, PhysiologicalNetherlands
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
University of Maryland, BaltimoreCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
National Institute on Drug Dependence, ChinaPeking University Sixth Hospital; Wuhan Wuchang HospitalUnknown
-
University of ZurichCompletedType 2 DiabetesSwitzerland
-
Massachusetts Institute of TechnologyMassachusetts General HospitalNot yet recruiting
-
Columbia UniversityNational Institute of Mental Health (NIMH); Massachusetts General Hospital; Dartmouth... and other collaboratorsSuspended
-
University of California, IrvineUniversity of California, Davis; University of California, San FranciscoCompletedStress, Psychological | Pregnancy Related | Glucose Intolerance During PregnancyUnited States
-
Medical University of South CarolinaCompletedTrauma | Posttraumatic Stress DisorderUnited States